NCT04637620View on ClinicalTrials.gov

NMDA Modulation in Major Depressive Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions
Major Depressive Disorder
Interventions
DRUG

NMDAE

Use of an NMDA enhancer for the treatment of MDD

DRUG

Sertraline

Use of SSRI as an active comparator

DRUG

Placebo Cap

Use of placebo as a comparator

Trial Locations (1)

Unknown

RECRUITING

Department of Psychiatry, China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

lead

China Medical University Hospital

OTHER